These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12116277)

  • 41. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma.
    Da Silva AM; Maciel RM; Da Silva MR; Toledo SR; De Carvalho MB; Cerutti JM
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5438-43. PubMed ID: 14602786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A RET double mutation in the germline of a kindred with FMTC.
    Bartsch DK; Hasse C; Schug C; Barth P; Rothmund M; Höppner W
    Exp Clin Endocrinol Diabetes; 2000; 108(2):128-32. PubMed ID: 10826520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.
    Hofstra RM; Fattoruso O; Quadro L; Wu Y; Libroia A; Verga U; Colantuoni V; Buys CH
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4176-8. PubMed ID: 9398735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
    Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?
    Gimm O; Marsh DJ
    J Endocrinol Invest; 2003 Apr; 26(4):381-3. PubMed ID: 12841548
    [No Abstract]   [Full Text] [Related]  

  • 46. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.
    Demeester R; Parma J; Cochaux P; Vassart G; Abramowicz MJ
    Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295841
    [No Abstract]   [Full Text] [Related]  

  • 47. Multiple endocrine neoplasia type 2B.
    Nakata S; Okugi H; Saitoh Y; Takahashi H; Shimizu K
    Int J Urol; 2001 Jul; 8(7):398-400. PubMed ID: 11442663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [C cell hyperplasia and medullary microcarcinomas of the thyroid].
    Guyetant S; Saint-Andre JP
    Ann Pathol; 2000; 20 Suppl():S39-44. PubMed ID: 11261296
    [No Abstract]   [Full Text] [Related]  

  • 49. Novel germline RET mutation segregating with papillary thyroid carcinomas.
    Rey JM; Brouillet JP; Fonteneau-Allaire J; Boneu A; Bastié D; Maudelonde T; Pujol P
    Genes Chromosomes Cancer; 2001 Dec; 32(4):390-1. PubMed ID: 11746981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early malignant progression of hereditary medullary thyroid cancer.
    Machens A; Niccoli-Sire P; Hoegel J; Frank-Raue K; van Vroonhoven TJ; Roeher HD; Wahl RA; Lamesch P; Raue F; Conte-Devolx B; Dralle H;
    N Engl J Med; 2003 Oct; 349(16):1517-25. PubMed ID: 14561794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
    Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
    Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
    Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
    Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.
    Jindrichova S; Kodet R; Krskova L; Vlcek P; Bendlova B
    J Mol Med (Berl); 2003 Dec; 81(12):819-23. PubMed ID: 14618242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.
    Eng C; Thomas GA; Neuberg DS; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Williams ED; Ponder BA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4310-3. PubMed ID: 9851769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
    Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
    Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.
    Huang CN; Wu SL; Chang TC; Huang SH; Chang TJ
    J Formos Med Assoc; 1998 Aug; 97(8):541-6. PubMed ID: 9747064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medullary thyroid carcinoma and lack of renal agenesis.
    Lombardo F; Filetti S; Crocetti U; Schlumberger M
    Thyroid; 2001 Jan; 11(1):93. PubMed ID: 11272104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.